The Food and Drug Administration (FDA) today began a public comment period for 21 transparency proposals the agency is considering. The proposals are part of a larger report the FDA issued on Wednesday. From the FDA:

Today the U.S. Environmental Protection Agency (EPA) and the Department of Homeland Security (DHS) took steps to increase the transparency of the response to BP's catastrophic oil spill in the Gulf of Mexico. The oil company's actions have been criticized for failing to disclose or monitor important information about the spill, including the quantity of oil erupting into the Gulf, the potential health impacts of the oil and the chemicals used to disperse it, and water and air quality information. The actions by EPA and DHS, although belated, are needed, welcome, and hopefully portend a higher standard for transparency that is enduring and comprehensive, not limited to responses to colossal disasters.

In recent months, failures at BP's Deepwater Horizon Gulf of Mexico facility injured and likely killed 11 oil rig workers and spawned an unprecedented environmental catastrophe; an explosion at Massey Energy's Upper Big Branch mine in West Virginia killed 29 miners; and a recall of millions of Toyota vehicles occurred after an acceleration defect was linked to injuries and deaths. These events have a few things in common, not the least of which is that they all illustrate a governmental failure to effectively regulate business activity and protect the public.

Yesterday, the Senate unveiled its version of legislation intended to cap climate-altering greenhouse gas emissions. Sens. John Kerry and Joseph Lieberman introduced the bill to much fanfare, yet the prospects of passage appear dim.